Venus Remedies has received approval from the Drug Controller General of India DCG(I)  to launch Cephalosporin, used in the treatment of Cystic Fibrosis

Cystic fibrosis is a hereditary disease that mainly affects the lungs and digestive system, causing progressive disability and early death for some patients.

Venus Remedies  is all set to launch this innovative therapy for APE/Cystis Fibrosis patients after completion of the multi-centered Phase II Clinical Trials. The commercial launch of this product shall be a boon to the Cystis Fibrosis patients being the only solution for the treatment of life threatening infections caused by P Aeruginosa / MRSA in these patients.